Heart and Vascular Health
32.7K views | +1 today
Follow
Heart and Vascular Health
Media, News & Topics on prevention, diagnosis & treatment of cardiovascular disease
Your new post is loading...
Your new post is loading...
Scooped by Seth Bilazarian, MD
Scoop.it!

The Rise of the Minimalist Workout

The Rise of the Minimalist Workout | Heart and Vascular Health | Scoop.it

People have been trying to figure out forever what the right amount of exercise is, but the focus lately is on the shortest period possible.

In the past, formal recommendations have called for a substantial amount of regular exercise. For example, published guidelines from the Health and Human Services Department in 2008 suggested 150 minutes of moderate exercise per week — the equivalent of five 30-minute walks. The guidelines added that 75 minutes of vigorous exercise a week, like jogging, could be substituted.

These guidelines were based on a large body of science showing that 150 minutes of moderate exercise was associated with a longer life span and a reduced risk of heart disease, diabetes and other illnesses.

Seth Bilazarian, MD's insight:

Studies have shown that 150 minutes of moderate exercise each week is associated with improved longevity and reduced risk of many diseases (obesity, diabetes).
Although these shorter more intense exercises are appealing for "busy" Americans, we don't know if the same long term health effects can be expected. In addition to the shorter time required in these workouts and therefore greater likelihood of adoption by those whop are motivated, another potential benefit is that the shorter duration of pain and discomfort with exercise may be an attractive aspect to help overcome the hurdles to exercise.

more...
Ellen Diane's comment, June 26, 2013 7:31 AM
I do intervals in my over 40 fitness class:) we do lots of cardio (cardiac:) bursts
Scooped by Seth Bilazarian, MD
Scoop.it!

Hot Dogs, Bacon And Red Meat Tied To Increased Diabetes Risk

Hot Dogs, Bacon And Red Meat Tied To Increased Diabetes Risk | Heart and Vascular Health | Scoop.it
People who upped their red meat intake saw their risk of Type 2 diabetes rise by nearly 50 percent.
more...
newagealternatives's comment, June 26, 2013 2:57 PM
These days, everything causes cancer.
Ellen Diane's comment, June 26, 2013 3:00 PM
yup
shelbylaneMD's curator insight, August 18, 2013 11:54 AM

Doesn't look ike a donut or cake either. 

Scooped by Seth Bilazarian, MD
Scoop.it!

Fish oil for Cardiovascular Outcomes in Diabetics

Fish oil for Cardiovascular Outcomes in Diabetics | Heart and Vascular Health | Scoop.it

Take Home Message:  In an era of evidence based medicine the Fish Oil strategy continues to disappoint for cardiovascular disease prevention. The main beneficiary of these repeated trials are the researchers.  Fish oil can be omitted, especially by patients who take many other medicines to help reduce the pill  burden.  Eat fish instead.

 

Daily supplementation with 1 g of n–3 fatty acids in daibetics did not reduce the rate of cardiovascular events over 6 years in patients at high risk for cardiovascular events.

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza (saxagliptin)

Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza (saxagliptin) | Heart and Vascular Health | Scoop.it

AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza(R) (saxagliptin) PRINCETON, N.J. & WILMINGTON, Del., Jun 19, 2013

In this study of adult patients with type 2 diabetes with either a history of established cardiovascular disease or multiple risk factors, Onglyza met the primary safety objective of non-inferiority, and did not meet the primary efficacy objective of superiority, for a composite endpoint of cardiovascular death, non-fatal myocardial infarction or non-fatal ischaemic stroke, when added to a patient’s current standard of care (with or without other anti-diabetic therapies), as compared to placebo. These preliminary SAVOR-TIMI-53 data are being analyzed and the study results will be submitted to the European Society of Cardiology (ESC) for potential presentation at the ESC Congress in September.

Seth Bilazarian, MD's insight:

My comment:  we have struggled to move the ball forward for diabetes care and prevention of heart attacks.  Despite more than a dozen oral drug options that improve blood sugar control, we lack evidence that this approach lowers the risk of strokes and heart attacks.  Blood pressure control and cholesterol treatment are proven strategies for risk reduction, but there remains scant evidence that improving blood sugar control makes a difference.  (It may make a difference on other important issues like diabetic eye and kidney concerns).

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

Handling inappropriate care appropriately in cardiology

Handling inappropriate care appropriately in cardiology | Heart and Vascular Health | Scoop.it

What do you do when your patient seeks inappropriate care—based on appropriate use and Choosing Wisely guidelines as well as your clinical judgment—from another cardiologist?  How do you then reconcile the situation with the patient?

more...
No comment yet.